Zhengye Biotechnology Holding Limited
NASDAQ:ZYBTDrug Manufacturers - Specialty & Generic
+$7.31 today
- Market cap
- $71.09M
- Beta
- -2.17
- P/E (TTM)
- -36.3
- EPS (TTM)
- -$1.50
Volume 0.02M
Average 0.10M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Zhengye Biotechnology Holding Limited
NASDAQ:ZYBT
Intrinsic Alpha fair value
Locked
Current Price
$1.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | -23.5% | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Recent growth has been strongest in Revenue at -23.5% over three years.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Surrozen, Inc. NASDAQ:SRZN | $236.36M | $31.61 | Not rated | -0.7 | +135.11% |
Pro-Dex, Inc. NASDAQ:PDEX | $210.11M | $65.66 | Undervalued | 17.1 | +121.17% |
Cardiol Therapeutics Inc. NASDAQ:CRDL | $120.66M | $1.00 | Not rated | -4.5 | -4.66% |
Apyx Medical Corporation NASDAQ:APYX | $118.37M | $2.81 | Not rated | -19.0 | -36.96% |
Sera Prognostics, Inc. NASDAQ:SERA | $77.99M | $2.01 | Not rated | -2.9 | -40.31% |
Instil Bio, Inc. NASDAQ:TIL | $41.23M | $6.08 | Not rated | -1.1 | -38.93% |
Oncolytics Biotech Inc. NASDAQ:ONCY | $37.13M | $0.37 | Not rated | -4.3 | -51.70% |
eXoZymes, Inc. NASDAQ:EXOZ | $35.55M | $3.83 | Not rated | -6.5 | -65.76% |
Continue the stock analysis
Jump to another research area for this company.